Partner Headlines - XNPT

  1. XenoPort Reports HORIZANT Included in New Expert Recommendations ...

    Benzinga
  2. Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

    Benzinga
  3. Jefferies Weighs In On Specialty Pharmaceuticals After Management ...

    Benzinga
  4. XenoPort Provides Highlights of HORIZANT Prescription Trends ...

    Benzinga
  5. CNBC's Stock Pops & Drops From December 30

    Benzinga
  6. Mid-Day Gainers From December 30: Neuroderm, Neonode And More

    Benzinga
  7. XenoPort Soars 9% Following Comments From RBC's Michael Yee

    Benzinga
  8. Mid-Morning Market Update: Markets Open Lower; Civeo Issues Weak ...

    Benzinga
  9. Morning Market Movers

    Benzinga
  10. Tuesday's #PreMarket Movers: Neuroderm, Microsoft, Medbox, Civeo ...

    Benzinga
  11. Post-Market Movers for Dec. 29: XNPT, RPRX, ACN Higher; CVEO, ...

    Benzinga
  12. Clinton Group Issues Release Reporting Availability of Proxy ...

    Benzinga
  13. XenoPort Files Definitive Proxy Materials and Mails Letter to ...

    Benzinga
  14. US Stock Futures Tumble; All Eyes On P&G, Honeywell Earnings

    Benzinga
  15. XenoPort Prices 12M Share Offering at $6.00/Share

    Benzinga
  16. XenoPort to Offer 10M Shares Common Stock

    Benzinga
  17. XenoPort Reports Feedback from FDA on XP23829

    Benzinga
  18. XenoPort Responds to Clinton Group Call for New CEO

    Benzinga
  19. Jeryl L Hilleman Named Ocera Therapeutics CFO

    Benzinga
  20. XenoPort Inc. Reports Operating Results (10-Q)

    GuruFocus
  21. UPDATE: Piper Jaffray Downgrades XenoPort to Neutral on Drug ...

    Benzinga
  22. UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on XenoPort

    Benzinga
  23. Socks Hitting 52-Week Highs

    Benzinga
  24. XenoPort Inc. Reports Operating Results (10-Q)

    GuruFocus
  25. Social Media Outlook for Friday July 27 (NYT, XNPT, GDOT, STRA)

    Benzinga
  26. XenoPort Announces Pricing of Public Offering of 6.15M Shares ...

    Benzinga
  27. XenoPort Announces Proposed Public Offering of Common Stock

    Benzinga
  28. XenoPort Announces Initiation of a Phase 1 Clinical Trial of ...

    Benzinga
  29. From Earlier, GSK and XenoPort Receive FDA Approval for Horizant® ...

    Benzinga
  30. UPDATE: Credit Suisse Initiates Outperform, $7 PT on XenoPort; ...

    Benzinga
  31. Xenoport Cuts 18 Jobs, Sees Charges of 1.4M, Names Vincent Angotti ...

    Benzinga
  32. UPDATE: Deutsche Bank Lowers Target on XenoPort to $7

    Benzinga
  33. Wedbush Lowers PT on XenoPort to $15

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!